EFTA02196925

Report Status: Partial 4 1) Quest EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR00I01214 Client #: EPSTEIN, JEFFREY Requisition: 0018435 MOSKOWITZ, BRUCE W DOB: 01/20/1953 ACE: 62 UCA/MOSKOWITZ BRUCE MD Gender: ii Attn: **1) GRJUNIV.CLINICAL Collected: 08/24/2015 Phone: 1411 N FLAGLER DR STE 7100 Received: 08/24/2015 / 19:39 EDT Patient II Reported: 08/25/2015 / 12:45 EDT WEST PALM BEACH, FL 33401 Health I Test Name In Range Out Of Range Reference Range Lab LIPID PANEL CHOLESTEROL, TOTAL 212 H 125-200 mg/dL MI HDL CHOLESTEROL 25 L > OR = 40 mg/dL MI TRIGLYCERIDES 673 H <150 mg/dL MI LDL-CHOLESTEROL <130 mg/dL (calc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 8.5 H < OR = 5.0 (calc) MI NON HDL CHOLESTEROL 187 H mg/dL (calc) MI Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 1.0 mg/L MI The above test was performed; however, the specimen was lipemic. Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 Years: hs-CRP mg/L Risk According to AHA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, may be associated with infection and inflammation. HOMOCYSTEINE 15.7 H <11.4 umol/L MI Homocysteine is increased by functional deficiency of folate or vitamin 812. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 118 H 65-99 mg/dL Fasting reference interval CLIENT SERVICES: 866.697.8378 SPECIMEN: NIR0°I0I2M PAGE1OF3 Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks arc the trademarks orQuest Diagnostics. EFTA_R1_00901591 EFTA02196925 Report Status: Partial 411 1Quest • :.: fly, : EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR001012M Client 4: EPSTEIN, JEFFREY Collected: 08/24/2015 MOSKOill , RU DOB: 01/20/1953 ACE: 62 Received: 08/24/2015 / 19:39 EDT Gender: M Reported: 08/25/2015 / 12:45 EDT Patient ID: Health ID: Test Name In Range Out Of Range Reference Range Lab UREA NITROGEN (BUN) 18 7-25 mg/dL CREATININE 1.09 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 72 > OR - 60 mL/min/1.73m2 eGFR AFRICAN AMERICAN 84 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO NOT APPLICABLE 6-22 (calc) SODIUM 139 135-146 mmol/L POTASSIUM 4.2 3.5-5.3 mmol/L CHLORIDE 108 98-110 mmol/L CARBON DIOXIDE 25 19-30 mmol/L CALCIUM 9.8 8.6-10.3 mg/dL PROTEIN, TOTAL 7.3 6.1-8.1 g/dL ALBUMIN 4.5 3.6-5.1 g/dL GLOBULIN 2.8 1.9-3.7 g/dL (calc) ALBUMIN/GLOBULIN RATIO 1.6 1.0-2.5 (calc) BILIRUBIN, TOTAL 0.7 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 64 40-115 U/L AST 16 10-35 U/L ALT 21 9-46 U/L URIC ACID 8.0 4.0-8.0 mg/dL MI Therapeutic target for gout patients: <6.0 mg/dL TSH 2.29 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 7.2 4.5-12.0 mcg/dL MI FREE T4 INDEX (T7) 2.2 1.4-3.8 T3 UPTAKE 30 22-35 % MI SED RATE BY MODIFIED MI WESTERGREN 6 < OR = 20 mm/h CBC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 6.3 3.8-10.8 Thousand/uL RED BLOOD CELL COUNT 5.17 4.20-5.80 Million/uL HEMOGLOBIN 15.1 13.2-17.1 g/dL HEMATOCRIT 44.3 38.5-50.0 % MCV 85.8 80.0-100.0 fL MCH 29.1 27.0-33.0 pg MCHC 33.9 32.0-36.0 g/dL RDW 14.3 11.0-15.0 % PLATELET COUNT 262 140-400 Thousand/uL MPV 7.5 7.5-11.5 fL ABSOLUTE NEUTROPHILS 3314 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2205 850-3900 cells/uL ABSOLUTE MONOCYTES 428 200-950 cells/uL ABSOLUTE EOSINOPHILS 315 15-500 cells/uL ABSOLUTE BASOPHILS 38 0-200 cells/uL NEUTROPHILS 52.6 LYMPHOCYTES 35.0 MONOCYTES 6.8 EOSINOPHILS 5.0 BASOPHILS 0.6 URINALYSIS, COMPLETE MI COLOR YELLOW YELLOW APPEARANCE CLEAR CLEAR CLIENT SERVICES: 866.697.8378 SPECUNEN:NIROOIOI2M PAGE20F3 Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks are the trademarks orQuest Diagnostics. EFTA_R1_00901592 EFTA02196926 Report Status: Partial 411 1Quest • fly. : EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR001012M Client #: EPSTEIN, JEFFREY Collected: 08/24/2015 MOSKOWITZ, BRUCE W DOB: 01/20/1953 ACE: 62 Received: 08/24/2015 / 19:39 EDT Gender: M Reported: 08/25/2015 / 12:45 EDT Patient ID: 090443348 Health ID: 8573003290851249 Teat Name In Range Out Of Range Reference Range Lab SPECIFIC GRAVITY 1.022 1.001-1.035 PH 5.5 5.0-8.0 GLUCOSE NEGATIVE NEGATIVE BILIRUBIN NEGATIVE NEGATIVE KETONES NEGATIVE NEGATIVE OCCULT BLOOD NEGATIVE NEGATIVE PROTEIN NEGATIVE NEGATIVE NITRITE NEGATIVE NEGATIVE LEUKOCYTE ESTERASE NEGATIVE NEGATIVE wag NONE SEEN < OR - 5 /HPF RBC NONE SEEN < OR - 2 /HPF SQUAMOUS EPITHELIAL CELLS NONE SEEN < OR = 5 /HPF BACTERIA NONE SEEN NONE SEEN /HPF HYALINE CAST NONE SEEN NONE SEEN /LPF C-REACTIVE PROTEIN <0.80 mgidL MI Please be advised that patients •taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.2 2.0-18.0 ng/mL MI TESTOSTERONE, TOTAL, MI MALES (ADULT), IA 129 L 250-827 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly less than 300 ng/dL may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a red-top tube with no gel. Two morning (8-10 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening for hypogonadism. PSA, TOTAL 0.6 < OR 4.0 ng/mL MI This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. PENDING TESTS: IILMOOLOBIN Ale CULTURE, URINE, ROUTINE VITAMIN BI2 PERFORMING SITE: MI QUEST DIAGNOSTICS-MIAMI. I 0200 COMMERCE PARKWAY. MIRAMAR. FL 33025-3938 Laboroxy Dustier GLDI L DORM MD PHD. CLJA: 10530277334 CLIENT SERVICES: 866.697.8378 SPECINIEN:N4R001012M PAGE3OF3 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks orQuest Diagnostics. EFTA_R1_00901593 EFTA02196927